// App-Quantinova.ai

CR15 : Insulin Allergy to Insulin Glargine 300 Units/Ml (Toujeo) and Other Insulin Derivatives in a Type 2 Diabetes Mellitus Patient

Researchers

Presenter

  • Hannah A Blair

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Anaphylaxis

  • Diabetes

Biomarkers

  • Immunoglobulin E

  • Insulin

Drug/Treatment

  • Insulin glulisine

  • Insulin glargine

  • Insulin detemir

  • Insulin regular

  • Insulin Aspart

  • Dapagliflozin

  • Neutral protamine Hagedorn insulin

  • Liraglutide

  • Omalizumab

  • Metformin Hydrochloride

  • NovoRapid

  • Acarbose

  • Apidra

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved